? Cancer Center Administration Abramson Cancer Center (ACC) Administration is responsible for supporting the ACC, an internationally renowned, NCI-Designated Comprehensive Cancer Center, in the management of resources and services required to facilitate the scientific mission of reducing the burden of cancer. These activities include strategic planning, evaluation, and decision-making; governance and management of the fiscal and administrative components of multiple ACC- and Cancer Center Support Grant (CCSG)-related activities; and management of Shared Resources, membership, the CCSG application, research and grant administration, and events and communication. Administration coordinates with other ACC activities (Community Outreach and Engagement, and Cancer Research Training and Education Coordination) as well as other support offices in the ACC, such as: Clinical Protocol and Data Management (CPDM)'s Department of Operations, Compliance and Monitoring; Development; and the Office of Legal Affairs. It represents the Center within the parent Institution and to the NCI and other external entities. The challenge of executing these priorities in a complex matrix cancer center requires Administration to have the talent, experience, and expertise necessary to support multiple constituent priorities (both internal and external), while maintaining dedication to their mission. ACC Administration comprises a cohesive group of highly experienced staff with the demonstrated proficiency necessary to skillfully meet the needs of ACC members, who accomplished unprecedented growth and success in the past decade. These key administrative staff members have clearly defined roles and responsibilities, with appropriate reporting lines both internally and within the larger Penn Medicine institution, to ensure that the administrative activities of the ACC are delivered in an effective and efficient manner.
Specific aims are to: 1) Administratively lead in the governance and decision-making processes of the ACC; 2) Deliver efficient and effective professional administrative oversight, financial management, and non-administrative and regulatory guidance to support cancer research activities, including all activities specifically related to the CCSG; and 3) Represent the interests of the ACC both within the parent Institution and with external groups, to ensure the Center adheres to, and helps shape, policies that govern its activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016520-45
Application #
10088740
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-15
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Morrison, Alexander H; Byrne, Katelyn T; Vonderheide, Robert H (2018) Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 4:418-428
Ojha, Rani; Leli, Nektaria M; Onorati, Angelique et al. (2018) ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discov :
Yan, Lesan; Amirshaghaghi, Ahmad; Huang, Dennis et al. (2018) Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy. Adv Funct Mater 28:
Waxman, Adam J; Clasen, Suparna; Hwang, Wei-Ting et al. (2018) Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 4:e174519
Han, Joseph; Lachance, Catherine; Ricketts, M Daniel et al. (2018) The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate. J Biol Chem 293:4498-4509
Reshef, Ran; Ganetsky, Alex; Acosta, Edward P et al. (2018) Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biol Blood Marrow Transplant :
Gangadhar, Tara C; Savitch, Samantha L; Yee, Stephanie S et al. (2018) Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. Pigment Cell Melanoma Res 31:73-81
Rosenfeld, Aaron M; Meng, Wenzhao; Luning Prak, Eline T et al. (2018) ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data. Front Immunol 9:2107
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253
Buljan, Vlado A; Graeber, Manuel B; Holsinger, R M Damian et al. (2018) Calcium-axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes. J Biol Phys 44:53-80

Showing the most recent 10 out of 1047 publications